A cost per live birth comparison of HMG and rFSH randomized trials

Author： Connolly Mark   De Vrieze Kathleen   Ombelet Willem   Schneider Dirk   Currie Craig  

Publisher： Reproductive Healthcare Ltd

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.17, Iss.6, 2008-12, pp. : 756-763

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of HMG versus r-FSH: response

By Al-Inany Hesham  

Reproductive BioMedicine Online, Vol. 16, Iss. 4, 2008-04 ,pp. : 600-600

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Efficacy and safety of HMG versus r-FSH

By Ulug Ulun   Bahçeci Mustafa  

Reproductive BioMedicine Online, Vol. 16, Iss. 4, 2008-04 ,pp. : 599-599

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

HMG versus rFSH for ovulation induction in developing countries: a cost–effectiveness analysis based on the results of a recent meta-analysis

By Al-Inany Hesham G   Abou-Setta Ahmed M   Aboulghar Mohamed A   Mansour Ragaa T   Serour Gamal I  

Reproductive BioMedicine Online, Vol. 12, Iss. 2, 2006-02 ,pp. : 163-169

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Ovulation induction with urinary FSH or recombinant FSH in polycystic ovary syndrome patients: a prospective randomized analysis of cost-effectiveness

By Gerli Sandro   Casini Maria Luisa   Unfer Vittorio   Costabile Loredana   Mignosa Marcella   Di Renzo Gian Carlo  

Reproductive BioMedicine Online, Vol. 9, Iss. 5, 2004-11 ,pp. : 494-499

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome

By Lan VTN   Norman RJ   Nhu GH   Tuan PH   Tuong HM  

Reproductive BioMedicine Online, Vol. 18, Iss. 4, 2009-04 ,pp. : 516-521

Reproductive Healthcare Ltd

Access to resources Recommend Favorite